Life ScienceCompany
Vixen Pharmaceuticals Ownership
Who owns Vixen Pharmaceuticals?
Vixen Pharmaceuticals is owned by Aclaris Therapeutics. It was acquired on March 28, 2016.
Vixen Pharmaceuticals Business Overview
Where is Vixen Pharmaceuticals headquartered?
Vixen Pharmaceuticals is headquartered in United States.
What sector is Vixen Pharmaceuticals in?
Vixen Pharmaceuticals is a life science company.
Life Science M&A Summary in 2016
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.
Join Mergr to view all 296 acquisitions of life science companies in 2016, including 34 acquisitions by private equity firms, and 262 by strategics.